SC
GMAB icon

Steven Cohen’s Genmab GMAB Stock Holding History

Steven Cohen’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Buy
+135,647
New +$3.61M ﹤0.01% 1977
2025
Q3 		– Sell
-538,500
Closed -$11.1M – 2458
2025
Q2 		$11.1M Sell
538,500
-385,367
-42% -$7.91M 0.02% 693
2025
Q1 		$18.1M Buy
923,867
+835,721
+948% +$17.5M 0.04% 477
2024
Q4 		$1.84M Buy
+88,146
New +$1.94M ﹤0.01% 1277
2024
Q3 		– Sell
-18,184
Closed -$457K – 2123
2024
Q2 		$457K Buy
+18,184
New +$516K ﹤0.01% 1463
2024
Q1 		– Sell
-101,100
Closed -$3.22M – 2335
2023
Q4 		$3.22M Sell
101,100
-177,501
-64% -$5.57M 0.01% 1065
2023
Q3 		$9.83M Buy
278,601
+101,101
+57% +$3.85M 0.03% 665
2023
Q2 		$6.75M Sell
177,500
-83,266
-32% -$3.32M 0.02% 713
2023
Q1 		$9.85M Buy
+260,766
New +$10M 0.03% 551
2021
Q4 		– Sell
-56,600
Closed -$2.47M – 1170
2021
Q3 		$2.47M Sell
56,600
-385,000
-87% -$17.3M 0.01% 769
2021
Q2 		$18M Buy
441,600
+212,900
+93% +$8.22M 0.08% 305
2021
Q1 		$7.51M Buy
+228,700
New +$8.6M 0.04% 492

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steven Cohen's GMAB Position: Q2 2026 in Review

Steven Cohen opened a new position in Genmab (GMAB) in Q2 2026: 135,647 shares worth $3.73M. The stake represents ﹤0.01% of the portfolio and ranks #1977 among its holdings. This is a return to the name: Steven Cohen previously reported a position in GMAB as recently as Q2 2025.

Steven Cohen first reported a position in GMAB in Q1 2021 and has held it in 12 quarters since. The position peaked at $18.1M in Q1 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Steven Cohen held 135,647 shares of Genmab worth $3.73M as of Q2 2026.
  • Genmab was a new Steven Cohen position in Q2 2026.
  • Genmab made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #1977 holding.
  • Steven Cohen first reported a position in Genmab in Q1 2021 and has held it in 12 quarters since.
  • Steven Cohen's Genmab position peaked at $18.1M in Q1 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.